Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01011361 · ClinicalTrials.gov registry record
Red Cell Mass and Plasma Volume Measurements in Elderly Men and Women With Anemia
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 5
- Enrollment target
NCT01011361: Completed study, sponsored by Stanford University.
NCT01011361 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01011361 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
On the basis that the clinical consequences of seemingly trivial levels of anemia are surprisingly severe, this study investigates if hemoglobin concentration accurately represents the underlying red cell mass in elderly patients with unresolved anemia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-04 |
| Est. Completion | 2011-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01011361
The ClinicalTrials.gov registry entry for NCT01011361 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01011361 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01011361 about?
NCT01011361 is a clinical study titled "Red Cell Mass and Plasma Volume Measurements in Elderly Men and Women With Anemia". On the basis that the clinical consequences of seemingly trivial levels of anemia are surprisingly severe, this study investigates if hemoglobin concentration accurately represents the underlying red cell mass in elderly patients with unresolved anemia.
What is the current status of trial NCT01011361?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2009-04. Estimated completion is 2011-06.
Who is sponsoring clinical trial NCT01011361?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.